🎙️ In a recent OncLive On Air podcast, David Morris, MD, FACS, and Alan Bryce, MD, discuss the FDA approval of rucaparib for patients with BRCA mutation–associated mCRPC.
🔗 Listen to the podcast: www.onclive.com/view/fda-app...
#ProstateCancer #mCRPC #PARPInhibitors #PrecisionOncology #Oncology

Ther Adv Med Oncol announces an open call for a Special Collection on Modern Approaches to Patient Selection in Breast Cancer.
Submissions addressing biomarkers, computational tools, and integrated clinical strategies are welcome.
buff.ly/t6TEH5G
#BreastCancer #MedicalOncology #PrecisionOncology

For Brain Health Awareness Month: using AI to explore health data for signatures that can predict brain tumour reoccurrence

#precisiononcology #personalizedmedicine #precisionmedicine #datasharing

A promising breakthrough to enhance the effectiveness of CAR-T therapies
🙂 Another encouraging news from Groupe UIG 🚀
Read: www.drugdiscoverynews.com/new-car-t-ma...
#OncologyInnovation #Immunotherapy #BiotechInnovation #CellTherapy #CancerResearch #NextGenMedicine #PrecisionOncology

Learn more about the project that FHS prof Dr. Samantha Pollard is undertaking as one of @terryfoxresearch.bsky.social new investigators!

#SFU #SFUResearch #SFUFHS #PediatricOncology #PrecisionOncology #CancerResearch

📢 DIGICORE's Q1 2026 Newsletter is out!
Working Group updates, Grants Portal, Ambassador Network & Save the Date for Connect to Win 2026 🇵🇹 Porto, 2–3 Nov.
👉 Read it: mailchi.mp/digicore-can...
📩 Subscribe: bit.ly/41oWe8p
🙏 Thanks to all contributors!
#DIGICORE #RWE #PrecisionOncology #CancerResearch

By bringing specialists together monthly to discuss real patient cases, this virtual board aims to shorten diagnostic odysseys and tailor safer cancer treatments for fragile biology. Collaboration really can change outcomes. #TumorBoard #PrecisionOncology #TCSC

Personalised treatment in childhood cancer: A journey through #NTRK fusion testing

🎬 Video for patients & families - please share

See the full video: cor2ed.com/precision-on...

Supported by an Independent Educational Grant from Bayer

#meded #moleculartesting #precisiononcology #MedSky

FDA Approves MyChoice CDx Companion Diagnostic for Niraparib in Ovarian Cancer | OncLive The regulatory agency green lit the use of MyChoice CDx as a companion diagnostic for niraparib in advanced ovarian cancer

🧬 The FDA has approved MyChoice CDx as the companion diagnostic for niraparib, enabling more precise identification of patients with HRD+ tumors who may be eligible to receive treatment with niraparib. #OvarianCancer #PrecisionOncology #PARPi #Oncology
Read more: www.onclive.com/view/fda-app...

Caris Life Sciences Launches Caris AI Insights to Identify Early Platinum Resistance in Ovarian Cancer Patients -- MedCloudInsider New Caris AI Insights capability analyzes molecular data to help identify platinum therapy resistance sooner.

Caris Life Sciences has introduced a new Caris AI Insights capability to help identify early platinum resistance in ovarian cancer using molecular and genomic data.

See how AI is shaping ovarian cancer care: https://ow.ly/RRAG50YvcS1

#PrecisionOncology #AI #OvarianCancer

Meet our team! We're led, governed & managed by an Executive Committee, with leadership & support from @terryfoxresearch.bsky.social.

“DHDP is a critical step toward modernizing Canada’s health data ecosystem..."
#datasharing #precisionmedicine #AI #ML #precisiononcology
www.dhdp.ca/about/our-team

Human DEAH-box helicase 8 regulates HSF1-mediated stress response and cancer-associated pre-mRNA splicing in tumour cells Abstract. Transcription factor heat shock factor 1 (HSF1) orchestrates the cellular stress response, promoting malignant transformation, unchecked prolifer

HSF1 drives cancer stress resilience but is hard to target—clever screen identifies spliceosome helicase DHX8 as a druggable regulator of HSF1 splicing→HSF1 program gone, cancer loses stress defenses. Editor's Choice in NAR Cancer. #PrecisionOncology #Spliceosome academic.oup.com/narcancer/ar...

National Patterns of Biomarker Testing in Colorectal, Lung, and Prostate Cancers: Insights From the NIH All of Us Research Program

Clinical Medicine Insights: Oncology
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#healthservices #healthpolicy #precisiononcology #openaccess

This review highlights the role of #DYRK #kinases in #DNADamageResponse, linking their activity to #cancer progression, while evaluating current DYRK inhibitors and positioning DYRK inhibition as a promising #PrecisionOncology strategy.

#OpenAccess: doi.org/10.1016/j.ge...

Review explores how generative AI could support precision oncology decision-making A narrative review examines how generative AI tools such as large language models and vision-language models could assist precision oncology by interpreting genomic data, matching patients to clinical...

Can generative #AI help oncologists cut through overwhelming cancer data while keeping patient safety first? 🤖🔬 www.news-medical.net/news/2026031... #PrecisionOncology

32-34 NEW PHARMA - In therapies PharmaTimes March explores today's life sciences landscape: patient autonomy where access to medicines is expected. Shifting politics, "super employees," ongoing innovation, GLP-1s, difficult-to-treat...

#obesity #diabetes #typeIIdiabetes #oncology #neurology #rarediseases #womenshealth #EliLilly #Akeso #SummitTherapeutics #precisionmedicine #immunotherapy #Alzheimersdisease #AstraZeneca #DaiichiSankyo #ADCs #precisiononcology #DrugstoWatch2026 #immunology #cardiology #CGTs
zurl.co/c8PJw

In this TJ Talks, prof. Curigliano talks with prof. Pruneri on the future of #PrecisionOncology and his commitment as next Presidet of ESMO @myesmo.bsky.social

🎙️omny.fm/shows/tumori-journal/how...

@oncoalert.bsky.social

Weekly reads 23/2/26 When context controls cancer: oxygen, space, niches and chromatin

Weekly reads 23/2/26:
When context controls cancer: oxygen, space, niches and chromatin
open.substack.com/pub/behindth...

Cancer isn’t just mutations: it’s metabolism, space, niches, and chromatin.

#CancerResearch #SingleCell #SpatialBiology #TumorMicroenvironment #PrecisionOncology

2nd International Conference on Cancer Research & Immuno-Oncology The conference provides an interactive environment where researchers, clinicians, and innovators can collaborate to accelerate progress in targeted

2nd International Conference on Cancer Research & Immuno-Oncology
April 3,4,5 2026
Atlantis the Royal, Palm Jumeirah - Crescent Road - Dubai

www.vydya.com/events/2nd-i...

#CancerResearch #ImmunoOncology #GenitourinaryCancer #GeneTherapy #PrecisionOncology
#OncologyConference #MedicalConference

Data Engineer: As Data Engineer you will play a critical role in designing and scaling the core infrastructure that powers the DHDP’s federated ecosystem.

www.dhdp.ca/about/careers

#hiring #AIML #datasharing #precisionmedicine #precisiononcology #softwareengineer #datascience

March 2025 saw the launch of the Digital Health Innovation Fund; $25 M targeted to bring together small- to medium-sized enterprises in project teams of two or more to advance AI and machine learning to accelerate precision medicine. #precisionmedicine #precisiononcology

This #STTT study identified glycolytic heterogeneity within the #PDAC #TumorMicroenvironment and proposes a novel glycolysis-based framework for patient stratification to guide personalized medicine & #PrecisionOncology.

#OpenAccess: doi.org/10.1038/s413...

‼️ New #ComboMATCH updates are enhancing patient care: ctDNA-based screening and progression biopsy results returned to treating physicians to inform future treatment decisions, advancing #PrecisionOncology for patients with specific DNA alterations. More ➡️ bit.ly/46Vdbug

This review describes aberrant #Sialylation as a critical driver of malignancy and #ImmuneSuppression, highlighting glycan-targeting strategies and sialyltransferase inhibitors as promising avenues for #PrecisionOncology.

#OpenAccess: doi.org/10.1016/j.ge...

This review describes aberrant #Sialylation as a critical driver of malignancy and #ImmuneSuppression, highlighting glycan-targeting strategies and sialyltransferase inhibitors as promising avenues for #PrecisionOncology.

#OpenAccess: doi.org/10.1016/j.ge...

Synapse: Your Connection to our MSK Authors
Meet: Fernando Costa Santini
Research Focus: Medicine; Assistant Attending

A phase II study of cabozantinib in patients with MET-altered lung cancers
synapse.mskcc.org/synapse/work...

#LungCancer #METAltered
#TargetedTherapy #PrecisionOncology

FGFR2b testing is becoming more relevant as biomarker-guided options grow. Have you seen more routine FGFR2b profiling in practice lately? #PrecisionOncology #TCSC

We’re excited to unveil IDT’s latest #NGS innovation roadmap—purpose-built to accelerate cancer breakthroughs and empower researchers working at the forefront of precision #oncologyresearch. 👏

Read more here: idtb.io/pa7j4h

#cancerresearch #precisiononcology #precisionhealth

Understanding how tumor cells switch states could reveal weak points to hit with new precision therapies, especially for notoriously tough cancers like pancreatic. #PrecisionOncology #TCSC

Prediction of Prognosis, Tumor Microenvironment, and Drug Treatment of Colorectal Cancer Based on Retinoic Acid-Related Genes

www.dl.begellhouse.com/journals/0ff...

#ColorectalCancer #CancerResearch #PrecisionOncology #JEPTO